News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Asuragen, Inc. Grants Armored RNA® Technology License to Becton, Dickinson and Company (BDX)


6/19/2012 10:57:46 AM

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that it has granted BD (Becton, Dickinson and Company), a global medical technology company, non-exclusive worldwide rights to incorporate Armored RNA® technology into its in vitro molecular diagnostics products. Under the terms of the Agreement, Asuragen will develop and supply reagents for BD Diagnostics in Asuragen’s cGMP manufacturing facility. Additional terms were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES